These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 24463469)

  • 1. The relationship of JAK2(V617F) and acquired UPD at chromosome 9p in polycythemia vera.
    Wang L; Swierczek SI; Lanikova L; Kim SJ; Hickman K; Walker K; Wang K; Drummond J; Doddapaneni H; Reid JG; Muzny DM; Gibbs RA; Wheeler DA; Prchal JT
    Leukemia; 2014 Apr; 28(4):938-41. PubMed ID: 24463469
    [No Abstract]   [Full Text] [Related]  

  • 2. PD-L1 overexpression correlates with JAK2-V617F mutational burden and is associated with 9p uniparental disomy in myeloproliferative neoplasms.
    Milosevic Feenstra JD; Jäger R; Schischlik F; Ivanov D; Eisenwort G; Rumi E; Schuster M; Gisslinger B; Machherndl-Spandl S; Bettelheim P; Krauth MT; Keil F; Bock C; Cazzola M; Gisslinger H; Kralovics R; Valent P
    Am J Hematol; 2022 Apr; 97(4):390-400. PubMed ID: 35015307
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Convergent mechanisms of somatic mutations in polycythemia vera.
    Wang K; Swierczek S; Hickman K; Hakonarson H; Prchal JT
    Discov Med; 2011 Jul; 12(62):25-32. PubMed ID: 21794206
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acquired uniparental disomy of chromosome 9p in hematologic malignancies.
    Wang L; Wheeler DA; Prchal JT
    Exp Hematol; 2016 Aug; 44(8):644-52. PubMed ID: 26646991
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Somatic JAK-2 V617F Mutational Analysis in Polycythemia Rubra Vera: a Tertiary Care Center Experience.
    Sultan S; Irfan SM; Khan SR
    Asian Pac J Cancer Prev; 2016; 17(3):1053-5. PubMed ID: 27039724
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous recombination of wild-type JAK2, a novel early step in the development of myeloproliferative neoplasm.
    Vilaine M; Olcaydu D; Harutyunyan A; Bergeman J; Tiab M; Ramée JF; Chen JM; Kralovics R; Hermouet S
    Blood; 2011 Dec; 118(24):6468-70. PubMed ID: 22161852
    [No Abstract]   [Full Text] [Related]  

  • 7. Megakaryocytic morphology and clinical parameters in essential thrombocythemia, polycythemia vera, and primary myelofibrosis with and without JAK2 V617F.
    Vytrva N; Stacher E; Regitnig P; Zinke-Cerwenka W; Hojas S; Hubmann E; Porwit A; Bjorkholm M; Hoefler G; Beham-Schmid C
    Arch Pathol Lab Med; 2014 Sep; 138(9):1203-9. PubMed ID: 25171702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the JAK2-V617F gene mutation in Turkish patients with essential thrombocythemia and polycythemia vera.
    Karkucak M; Yakut T; Ozkocaman V; Ozkalemkas F; Ali R; Bayram M; Gorukmez O; Ocakoglu G
    Mol Biol Rep; 2012 Sep; 39(9):8663-7. PubMed ID: 22722988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clonal heterogeneity in polycythemia vera patients with JAK2 exon12 and JAK2-V617F mutations.
    Li S; Kralovics R; De Libero G; Theocharides A; Gisslinger H; Skoda RC
    Blood; 2008 Apr; 111(7):3863-6. PubMed ID: 18195094
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JAK2 V617F/C618R mutation in a patient with polycythemia vera: a case study and review of the literature.
    Yoo JH; Park TS; Maeng HY; Sun YK; Kim YA; Kie JH; Cho EH; Song J; Lee KA; Suh B; Choi JR
    Cancer Genet Cytogenet; 2009 Feb; 189(1):43-7. PubMed ID: 19167611
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A gain-of-function mutation of JAK2 in myeloproliferative disorders.
    Kralovics R; Passamonti F; Buser AS; Teo SS; Tiedt R; Passweg JR; Tichelli A; Cazzola M; Skoda RC
    N Engl J Med; 2005 Apr; 352(17):1779-90. PubMed ID: 15858187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Extent of hematopoietic involvement by TET2 mutations in JAK2V⁶¹⁷F polycythemia vera.
    Swierczek SI; Yoon D; Bellanné-Chantelot C; Kim SJ; Saint-Martin C; Delhommeau F; Najman A; Prchal JT
    Haematologica; 2011 May; 96(5):775-8. PubMed ID: 21273266
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of a new JAK2 D620E mutation in addition to V617F in a patient with polycythemia vera.
    Grünebach F; Bross-Bach U; Kanz L; Brossart P
    Leukemia; 2006 Dec; 20(12):2210-1. PubMed ID: 17008888
    [No Abstract]   [Full Text] [Related]  

  • 14. Detection of JAK2 Exon 12 Mutations in JAK2 V617F-Negative Polycythemia Vera Patients by Cloning Technique.
    Leszczynska A; Grzenkowicz-Wydra J; Chmielewska-Gorycka L; Bieniaszewska M; Hellmann A
    Acta Haematol; 2016; 136(2):123-8. PubMed ID: 27410038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Iron deficiency in JAK2 exon12 and JAK2-V617F mutated polycythemia vera.
    Liu D; Xu Z; Zhang P; Qin T; Li B; Qu S; Pan L; Cai W; Liu J; Wang H; Sun Q; Sun X; Jiao M; Gao Q; Shi Z; Huang H; Huang G; Gale RP; Xiao Z
    Blood Cancer J; 2021 Sep; 11(9):154. PubMed ID: 34535626
    [No Abstract]   [Full Text] [Related]  

  • 16. Switch in X-inactivation in a JAK2 V617F-negative case of polycythemia vera with two acquired X-autosome translocations.
    Manola KN; Stavropoulou C; Georgakakos VN; Zoi K; Fisfis M; Evmorfiadis I; Zoi C; Pantelias GE; Stefanoudaki K; Sambani C
    Leuk Res; 2007 Jul; 31(7):1009-14. PubMed ID: 17204324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The JAK2 V617F allele burden in essential thrombocythemia, polycythemia vera and primary myelofibrosis--impact on disease phenotype.
    Larsen TS; Pallisgaard N; Møller MB; Hasselbalch HC
    Eur J Haematol; 2007 Dec; 79(6):508-15. PubMed ID: 17961178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acquired uniparental disomy of chromosome 9p is a frequent stem cell defect in polycythemia vera.
    Kralovics R; Guan Y; Prchal JT
    Exp Hematol; 2002 Mar; 30(3):229-36. PubMed ID: 11882360
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An increase in diagnostic JAK2 V617F mutation testing: Is masked polycythaemia vera the explanantion?
    Langabeer SE
    Eur J Intern Med; 2018 Jun; 52():e37-e38. PubMed ID: 29622375
    [No Abstract]   [Full Text] [Related]  

  • 20. The development of gastric cancer in a patient with polycythemia Vera, 3P deletion, and JAK2 V617F mutation.
    Ayvaz O; Yavasoglu I; Kadikoylu G; Meydan N; Barutca S; Bolaman Z
    J Gastrointest Cancer; 2010 Dec; 41(4):254-6. PubMed ID: 20306156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.